SR-9011 Transdermal

SR-9011 functions as a potent agonist of the Rev-Erbα and Rev-Erbβ nuclear receptors, key regulators of the mammalian circadian clock and metabolic homeostasis. Preclinical data indicate SR-9011 modulates expression of genes governing lipogenesis, gluconeogenesis, and the inflammatory cascade. Research in rodent models has demonstrated reductions in adiposity, improved insulin sensitivity, and attenuation of inflammatory markers upon administration. The compound’s ability to entrain circadian gene networks makes it a subject of interest in chronobiology, metabolic syndrome research, and anti-inflammatory drug discovery. Delivered via transdermal formulation to facilitate consistent dermal absorption in research models.

Molecular Information

Storage Information

Protect from light and moisture. Transdermal formulations should be stored in a cool environment to ensure proper permeation based research may be conducted. Do not freeze

Quality Assurance & Supplier Commitment

We maintain longstanding relationships with leading peptide lyophilizers and raw material suppliers, selected through an exhaustive vetting process that evaluates manufacturing practices, analytical capabilities, and regulatory compliance. Our API sourcing protocol includes certificate of analysis review, third-party analytical testing, and periodic supplier audits to ensure consistent purity, potency, and sterility standards across all product lines.

Each batch undergoes meticulous quality control verification prior to release, including HPLC purity analysis, mass spectrometry confirmation, and endotoxin testing where applicable. Our commitment to sourcing integrity ensures researchers receive material of the highest available quality.